• 1.大連醫(yī)科大學(xué)附屬四院普外科(大連116001）;;
  • 2.白求恩醫(yī)科大學(xué)附屬三院基本外科（長春130021）;;
  • 3.大連醫(yī)科大學(xué)附屬二院（大連116023）;

目的探討c-met及p53表達(dá)在乳腺癌血管生成中的作用及其臨床意義。方法應(yīng)用SP免疫組化方法和計算機(jī)圖像分析技術(shù)，對80例乳腺癌、20例乳腺纖維腺瘤的微血管計數(shù)（MVC）和c-met及p53蛋白的表達(dá)進(jìn)行定量測定。結(jié)果乳腺癌組織中MVC和cmet及p53的陽性表達(dá)與乳腺癌的組織學(xué)分級、腋窩淋巴結(jié)轉(zhuǎn)移及腫瘤分期有關(guān) (P＜0.01)。MVC在c-met及p53表達(dá)陽性者明顯高于c-met及p53表達(dá)陰性者，兩者間差異有顯著性意義 (P＜0.01)。結(jié)論cmet及p53共同參與調(diào)控乳腺癌的腫瘤血管生成。

引用本文： 尹家俊,宋燕,王曉波,曲文志,孟慶成. 乳腺癌中c-met及p53表達(dá)與血管生成的關(guān)系. 中國普外基礎(chǔ)與臨床雜志, 2002, 9(5): 316-318. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma [J]. Hum Pathol, 1992; 23(7)∶755.
2. Weidner N, Folkman J, Pozza F, et al . Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma [J]. J Natl Cancer Inst, 1992; 84(24)∶1875.
3. Jin L, Fuchs A, Schnitt SJ, et al. Expression of scatter factor and cmet receptor in benign and malignant breast tissue [J]. Cancer, 1997; 79(4)∶749.
4. Hollstein M, Sidransky K, Vogelstein B, et al. p53 mutations in human cancers [J]. Science, 1991; 253(5015)∶49.
5. Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert Lecture: the role of the p53 tumoursuppressor gene in tumorigenesis [J]. Br J Cancer, 1994; 69(3)∶409.
6. Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo [J].Proc Natl Acad Sci U S A, 1993; 90(5)∶1937.
7. Xu M, Kumar D, Srinivas S, et al. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity [J]. Hum Gene Ther, 1997; 8(2)∶177.
  1. 1. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma [J]. Hum Pathol, 1992; 23(7)∶755.
  2. 2. Weidner N, Folkman J, Pozza F, et al . Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma [J]. J Natl Cancer Inst, 1992; 84(24)∶1875.
  3. 3. Jin L, Fuchs A, Schnitt SJ, et al. Expression of scatter factor and cmet receptor in benign and malignant breast tissue [J]. Cancer, 1997; 79(4)∶749.
  4. 4. Hollstein M, Sidransky K, Vogelstein B, et al. p53 mutations in human cancers [J]. Science, 1991; 253(5015)∶49.
  5. 5. Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert Lecture: the role of the p53 tumoursuppressor gene in tumorigenesis [J]. Br J Cancer, 1994; 69(3)∶409.
  6. 6. Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo [J].Proc Natl Acad Sci U S A, 1993; 90(5)∶1937.
  7. 7. Xu M, Kumar D, Srinivas S, et al. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity [J]. Hum Gene Ther, 1997; 8(2)∶177.